Navigation Links
Thoratec Announces FDA Approval of HeartMate II(R) for Destination Therapy
Date:1/20/2010

eartMate II's experience with BTT patients, and we look forward to facilitating the adoption of this therapy among a wider group of patients. We believe the HeartMate II represents clinically proven technology, and when combined with our new HeartMate peripherals, offers a compelling and economically viable therapy for heart failure patients. Our focus now is to educate the referring cardiologist community about the efficacy of the device and continue to help VAD centers bring on DT programs. Through our training initiatives, support for centers and educational programs targeted to referring cardiologists, we are committed to advancing the field of mechanical circulatory support and improving the outcomes for a much broader population of advanced-stage heart failure patients," Burbach continued.

The HeartMate II and the HeartMate XVE are the only devices approved by the FDA for both DT and BTT. A continuous flow device, the HeartMate II is an implantable LVAS powered by a rotary pumping mechanism and is designed to have a much longer functional life than pulsatile devices and to operate more simply and quietly. The device provides blood flow through the circulatory system on a continuous basis with only one moving part. It is also smaller and easier to implant than previously approved pulsatile devices.

Thoratec is a world leader in therapies to address advanced-stage heart failure. The company's product lines include the Thoratec® VAD (Ventricular Assist Device) and HeartMate LVAS with more than 14,000 devices implanted in patients suffering from heart failure. Additionally, its International Technidyne Corporation (ITC) division is a leader in point-of-care blood testing and skin incision products. Thoratec is headquartered in Pleasanton, California. For more information, visit the company's web sites at

SOURCE Thoratec Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Thoratec Announces FDA Approval of HeartMate II(R) for Bridge-To-Transplantation
2. Thoratec Says Interim Data Analysis Demonstrates Statistical Superiority for the HeartMate II(R) in Destination Therapy Trial
3. Thoratec Reports 14 Percent Growth in Cardiovascular Division Sales as Third Quarter Revenues Increase Nine Percent
4. Thoratec Presentation at Canaccord Adams Conference to be Webcast
5. Thoratec Investor Meeting to Review HeartMate II (R) Destination Therapy Trial Data to Be Webcast
6. Thoratec Presentation at Piper Jaffray Conference to be Webcast
7. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
8. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
9. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
10. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
11. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... Inc. (NASDAQ: QCOR ) today reported financial results ... Ended 06/30/14Three Months Ended 06/30/13 ,  Percentage ChangeGAAP Net Sales ... Net Sales , $278.8 Million , $196.1 Million , ... $1.12 , 37% Non-GAAP Diluted EPS , ... Months Ended 06/30/14Six Months Ended 06/30/13 ,  Percentage ChangeNet Sales ...
(Date:7/24/2014)... 24, 2014 Cancer patients in the west of ... cancer treatment closer to home when a new radiotherapy center ... Medical Systems (NYSE: VAR ) has been selected ... in June for four TrueBeam™ medical linear accelerators. ... and efficient radiotherapy and radiosurgery treatments, will replace older treatment ...
(Date:7/24/2014)...  Bruin Biometrics (BBI), a pioneer in biometric-sensor ... weeks of clinical briefings to over 200 pressure ... substantial concurrence on both the clinical validity of ... BBI,s SEM Scanner. "From our ... drawn from the European Wound Management Association (EWMA) ...
Breaking Medicine Technology:Questcor Reports Record Second Quarter Financial Results 2Questcor Reports Record Second Quarter Financial Results 3Questcor Reports Record Second Quarter Financial Results 4Questcor Reports Record Second Quarter Financial Results 5Questcor Reports Record Second Quarter Financial Results 6Questcor Reports Record Second Quarter Financial Results 7Questcor Reports Record Second Quarter Financial Results 8Questcor Reports Record Second Quarter Financial Results 9Questcor Reports Record Second Quarter Financial Results 10Questcor Reports Record Second Quarter Financial Results 11Questcor Reports Record Second Quarter Financial Results 12Questcor Reports Record Second Quarter Financial Results 13Questcor Reports Record Second Quarter Financial Results 14Questcor Reports Record Second Quarter Financial Results 15Questcor Reports Record Second Quarter Financial Results 16Questcor Reports Record Second Quarter Financial Results 17Questcor Reports Record Second Quarter Financial Results 18Questcor Reports Record Second Quarter Financial Results 19Questcor Reports Record Second Quarter Financial Results 20Questcor Reports Record Second Quarter Financial Results 21Questcor Reports Record Second Quarter Financial Results 22Questcor Reports Record Second Quarter Financial Results 23Questcor Reports Record Second Quarter Financial Results 24Questcor Reports Record Second Quarter Financial Results 25Questcor Reports Record Second Quarter Financial Results 26Questcor Reports Record Second Quarter Financial Results 27Questcor Reports Record Second Quarter Financial Results 28Varian Medical Systems Selected to Equip First Satellite Radiotherapy Center in Scotland 2Varian Medical Systems Selected to Equip First Satellite Radiotherapy Center in Scotland 3Bruin Biometrics Secures Support of EU Scientific Community for its SEM Scanner Technology 2
... ADDISON, Texas, May 11, 2011 ULURU Inc. ... scheduled a conference call to discuss the first quarter ended March ... on Tuesday, May 17, 2011 at 9:00 a.m. Eastern Time. ... for international callers dial (850) 429-1388 (access code 23748#) five to ...
... May 11, 2011 HCB Health, one of the ... and the leading healthcare agency in the Southwest, won ... the 22nd annual Manny Awards, a national competition honoring ... for a consumer campaign supporting Sound Surgical Technologies, VASER® ...
Cached Medicine Technology:ULURU Inc. Announces Conference Call to Discuss Financial Results for the First Quarter Ended March 31, 2011 and to Provide a Business Update 2HCB Health Wins Manny Award for Best Medical Device Campaign 2
(Date:7/24/2014)... Journal of Oral Implantology —Success of a ... the alveolar ridge—an indication of the amount of bone ... exist, each with their own advantages, to determine bone ... highlighted as a strategy for treating horizontally collapsed alveolar ... comparison of two commonly used techniques , the ...
(Date:7/24/2014)... bearing human breast tumors, exposure to dim light at ... drug tamoxifen, according to data published in Cancer ... Cancer Research. The negative effects of dim light exposure ... melatonin supplement during the night. , "Resistance to tamoxifen ... breast cancer," said Steven M. Hill, PhD, professor of ...
(Date:7/24/2014)... 2014 Vulnerable populations such as ... are disproportionately affected by food security, despite the ... the United States, according to a new report ... the Consolidated Appropriations Act, 2014 (P.L. 113-76), Congress ... Nutrition Service (FNS) to contract with a nonprofit ...
(Date:7/24/2014)... July 24, 2014 In a July 9th ... and founder of Lotus Blossom Consulting LLC , was ... Three Ways to Cut the High Cost of Infertility ... minimize costs is to maximize your chance of success from ... choosing a clinic. , “I am always happy to ...
(Date:7/24/2014)... appears to increase the risk for head and neck cancer ... with DM, but the risk of HNC in patients with ... cancer is the sixth most common type of cancer. It ... an estimated 650,000 new cancer cases and 350,000 cancer deaths ... Insurance Research Database to examine the risk of HNC in ...
Breaking Medicine News(10 mins):Health News:A Comparison of Graft Techniques for the Alveolar Ridge Prior to Oral Implant 2Health News:A Comparison of Graft Techniques for the Alveolar Ridge Prior to Oral Implant 3Health News:Exposure to dim light at night may make breast cancers resistant to tamoxifen 2Health News:Report: Vulnerable Populations Disproportionately Affected by Food Security, Despite Public Programs 2Health News:Report: Vulnerable Populations Disproportionately Affected by Food Security, Despite Public Programs 3Health News:Mindy Berkson, Infertility Expert and Founder, Lotus Blossom Consulting LLC: Leading the Pathway to Parenthood 2Health News:Mindy Berkson, Infertility Expert and Founder, Lotus Blossom Consulting LLC: Leading the Pathway to Parenthood 3
... has shown that a synthetic derivative of a common North ... living longer. ,University of Michigan scientist Richard ... called NDGA. ,While presenting the preliminary results of ... Association, he said that male mice fed a normal diet ...
... monsoons making a grand entry into Kerala, tourist resorts and ... The rainy season, experts say, is the best time for ... India, it has only in recent years that it has ... in the months June-August. ,According to ayurveda specialists, ...
... one hundred Long Island AARP members gathered today to rally ... 2007 Legislative Session in Albany that will help make ... phone works in an emergency. The AARP members took their ... tour of Nassau and Suffolk counties that stopped at more ...
... An awful lot of sexuality in Enrique Iglesias lyrics is apparently ... Spanish singer recently revealed that he was also a part of ... ,When asked if he thinks about sex more than other ... ,'No. I read that males think about sex every ...
... in Australia have relatively low rates of hospital use, ... health care, refugee health specialists said in the ... ,Deputy Director of the Melbourne-based Refugee Health Research ... in Victoria over the six financial years to June ...
... have hypothesized that the fetus can be exposed to ... the mother has been exposed, and this may have ... (e.g. eczema and asthma) later in an infants life). ... of an inability to detect antigen-specific T cells in ...
Cached Medicine News:Health News:Common Desert Shrub may Increase Longevity 2Health News:Ayurveda Resorts in Kerala Gear Up for the Monsoon Season 2Health News:Ayurveda Resorts in Kerala Gear Up for the Monsoon Season 3Health News:Long Island Seniors Rally for Rx Affordable Prescription Drugs and Cell Phone Protections 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: